SCHEMBL6653685

SCHEMBL6653685

CCCN(CCC)CCC[C@H](NC(=O)c1ccc(CNC(C)c2ncc[nH]2)cc1)C(=O)NCCCOC(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.40
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 1/20 0.36
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
PLG P00747 1/20 0.35
NPY4R P50391 1/20 0.35
CTSS P25774 2/20 0.34
DDR1 Q08345 1/20 0.34
MAPK14 Q16539 1/20 0.34
DDR2 Q16832 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 1/20 0.34
TP53 P04637 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6652952 0.89 CXCR4 (0.41) CXCR4L3MBTL1DRD2DRD4DRD3
SCHEMBL6653370 0.87 CXCR4 (0.42) CXCR4LMNAALDH1A1DRD2DRD4
SCHEMBL6652954 0.87 CXCR4 (0.49) CXCR4LMNAMAPK1TSHRL3MBTL1
SCHEMBL6658151 0.85 GAA (0.35) LMNATSHRL3MBTL1ALDH1A1DRD2
SCHEMBL6659666 0.83 HDAC3 (0.46) MAPK1TSHRALDH1A1CTSL
SCHEMBL1638431 0.82 CXCR4 (0.52) CXCR4L3MBTL1DRD2DRD4DRD3
SCHEMBL6656540 0.81 CXCR4 (0.52) CXCR4LMNAGAA
SCHEMBL6653683 0.80 LMNA (0.39) CXCR4LMNAMAPK1TSHRL3MBTL1
SCHEMBL6654654 0.79 CXCR4 (0.43) CXCR4DRD2DRD4DRD3DDR1
SCHEMBL6653573 0.75 CXCR4 (0.51) CXCR4L3MBTL1DRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040254221-A1 Novel Nitrogenous Compound and use thereof KUREHA CORPORATION (JP) 2004-12-16 US claimed
EP-1431290-A1 NOVEL NITROGENOUS COMPOUND AND USE THEREOF Kureha Chemical Industry Co., Ltd. (JP) 2004-06-23 EP claimed
US-20040254221-A1 Novel Nitrogenous Compound and use thereof KUREHA CORPORATION (JP) 2004-12-16 US disclosed
EP-1431290-A1 NOVEL NITROGENOUS COMPOUND AND USE THEREOF Kureha Chemical Industry Co., Ltd. (JP) 2004-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254221-A1 Novel Nitrogenous Compound and use thereof NGLY1, NOD1, CCR1 CXCR4 88/4885LMNA 3004/4885MAPK1 419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.